Drugs / hUCB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06377982 | Sep 2025 → Sep 2027 expected | cerebral palsy | StemCyte International, Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hUCB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06377982 ↗ |
| Modality | Cell therapy | “allogeneic human umbilical cord blood infusion” NCT06377982 ↗ |